Connect with us
Novartis has the worst rating in the European pharmaceutical industry, while AstraZeneca downgrades its expectations from exceptional to neutral. Credit Suisse has also analyzed the Spanish...
Immuno-oncology and molecular oncology are two of Sanofi's most promising bets to tackle some of the most difficult-to-treat cancers. While immuno-oncology research is focused on finding...
At the beginning of October, Sanofi, Mylan, and Seqirus were awarded the supply of common flu vaccines nationwide for a total of $321 million (€277 million)....
The cost of products sold by Sanofi was $3.25 billion (€2.68 billion) in the first quarter of 2021, down 6.3%. Selling and general expenses also fell...
The company says the operating context of the self-care industry is different from that of the prescription drug industry. Sanofi, which will continue to own its...
The combined profit of Pfizer, Roche, Johnson&Johnson (J&J), Sanofi, Merck and Novartis exceeds $70.52 billion (€58 billion) in 2020. Sanofi achieved a profit of $16.06 billion...
The group of projects that are in the most advanced stage of testing to find the coronavirus vaccine is joined by the vaccine developed by the...
Sanofi is under fire for offering anti-dengue vaccine Dengvaxia to the Philippines while it is still on clinical trial.